DM
Drugs Made In America Acquisition Corp. Units
DMAAU · NASDAQ
$10.99 +0.00% (+$0.00)
1M +1.56%
Market Cap $257.5M
P/E Ratio 42.25x
Div. Yield -
ROE 3.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/E 42.25x
PEG N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
37 /100
Average ROA 4.15%
Asset turnover 0.00x
ROE 3.53%
Debt
0 /100
High Current ratio 0.02x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.19x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na DMAAU
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Roger Bendelac
Employees
2
Headquarters
New York